Company Information
CIN
Status
Date of Incorporation
29 April 1971
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2021
Last Annual Meeting
27 August 2021
Paid Up Capital
90,110,185
Authorised Capital
219,500,000
Directors
Pankaj Bhuneshwar Patwari
Director/Designated Partner
about 2 years ago
about 2 years ago
Shweta Jalan
Director/Designated Partner
about 2 years ago
about 2 years ago
Bharat Vinod Daftary
Director/Designated Partner
over 2 years ago
over 2 years ago
Gautam Vinod Daftary
Director/Designated Partner
over 2 years ago
over 2 years ago
Anupama Diwakar Pai
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Sanjiv Hari Navangul
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Chirag Ashokbhai Mehta
Manager/Secretary
over 5 years ago
over 5 years ago
Abhijit Mangalmoy Mukherjee
Director/Designated Partner
almost 6 years ago
almost 6 years ago
Bhaskar Vemban Iyer
Director/Designated Partner
almost 6 years ago
almost 6 years ago
Jayesh Tulsidas Merchant
Director/Designated Partner
almost 6 years ago
almost 6 years ago
Nitin Jagannath Deshmukh
Nominee Director
over 8 years ago
over 8 years ago
Ajeet Singh Karan
Director
about 11 years ago
about 11 years ago
Rohan Pradeep Shah
Director
about 16 years ago
about 16 years ago
Past Directors
Suresh Lal Goklaney
Additional Director
over 8 years ago
over 8 years ago
Balasubramaniam Venkatasubramaniam Kollengode
Ceo(kmp)
over 9 years ago
over 9 years ago
Nafeesa Adil Moloobhoy
Additional Director
about 10 years ago
about 10 years ago
Samir Vinodray Raval
Company Secretary
over 10 years ago
over 10 years ago
Milind Makarand Vaidya
Whole Time Director
almost 12 years ago
almost 12 years ago
Girish Bakre
Director
over 12 years ago
over 12 years ago
Manu Prafull Daftary
Director
over 12 years ago
over 12 years ago
Kavita Khanna Vinod
Additional Director
over 12 years ago
over 12 years ago
Suketu Viren Shah
Additional Director
almost 16 years ago
almost 16 years ago
Kamalesh Sarangi
Alternate Director
about 16 years ago
about 16 years ago
Cynthia Christine Dsouza
Director
over 17 years ago
over 17 years ago
Sunil Vasant Diwakar
Alternate Director
over 19 years ago
over 19 years ago
Prakash Dharshibhai Shah
Director
over 23 years ago
over 23 years ago
Dilip Jayantilal Mehta
Director
over 23 years ago
over 23 years ago
Patents
A process for preparation of clear aqueous composition of propofol suitable for parenteral administration is described. The compositions essentially consist of an inclusion complex of propofol with 2-hydroxypropyl-β-cyclodextrin. Complexation of propofol with 2-hydroxypropyl-β-cyclodextrin produces a clear aqueous c...
A process for manufacture of a low toxicity sterile Amphotericin B aqueous composition suitable for parenteral administration containing phospholipids and atleast 0.1% w/v sodium chloride; the process for manufacture comprising,
(i) dissolving one or more phospholipids in a single solvent or in a mixture of solvent...
Anti-tetanus monoclonal antibodies and methods for the production thereof.
The present invention provides stable, clear, aqueous Ifosfamide compositions for parenteral administration having reduced dose dependent toxicities of Ifosfamide. Also the compositions have reduced urotoxicity over and above the concomitant use of the uroprotective agent, Mesna. Aqueous compositions of Ifosfamide c...
A sterile, low toxicity, stable, aqueous, oxazaphosphorine-containing composition with mesna for parenteral administration has been described. The invention describes compositions that are stable and have low urotoxicity
Monoglycerides, especially Monolaurin, are used to protect intravenously administrable oil-in -water emulsion composition against growth of E. coli, P.aeruginosa S.aureus and C. albicans. The compositions can be medicaments containing lipophilic drugs, especially propofol, and/ or total intravenous nutritional compo...
The invention discloses a stable intravenous Propofol oil-in-water emulsion composition having mixed preservatives of low toxicity that is capable of withstanding accidental contamination of bacteria and fungi.The preservative system employed comprising of monoglyceryl ester of lauric acid(Monolarurin)and a member s...
The invention discloses an aqueous anaesthetic Propofol composition that is stable, autoclave sterilized, suitable for parental administration, having reduced incidence of pain upon injection. The composition comprises propofol, 2-hydroxypropyl-β-cyclodextrin and a local anaesthetic, Lignocaine.
...
Anti-RhD monoclonal antibodies and methods for the production thereof
The present invention provides an injectable oil-in-water nanoemulsion having average particle size less than 200nm comprising: water insoluble drugs in the concentration of at least 0.01% w/v; oils selected from one or more vegetable oils such as Soya oil, olive oil; MCT oil or mixture thereof, in a concentration o...
Anti-RhD monoclonal antibodies and methods for the production thereof.
Anti-RhD monoclonal antibodies and methods for the production thereof.
The present invention discloses Propofol oil-in-water emulsion composition comprising capric and / or its water soluble alkali salts as preservative to prevent proliferation of microorganisms due to any accidental contamination of the composition during prolonged intravenous administration.
A safety housing based implant/medicament injecting system. System includes a needle assembly prefilled implant/medicament for injection and an injecting needle/cannula, a housing for accommodating the needle assembly under usual bias inside said housing , a plunger means having a plunger rod configured for stage wi...
The present invention is disclosing an automated and end of content blocking disposable injector system comprising a housing having an injection container with injecting content for delivery at a dispensing end, an injecting content pusher means in axial operative communication with the injection container for dosag...
The present invention relates to an improved purification process for isolating anti-Rhesus D monoclonal antibodies and their antigen-binding fragments. The improved process involves a series of purification techniques, including affinity chromatography, low pH inactivation, anion exchange and cation exchange chroma...
Registered Trademarks
[Class : 5] Medicinal & Pharmaceutical Preparations & Substances.
[Class : 5] Medicinal & Pharmaceutical Preparation & Substances.
[Class : 5] Medicinal & Pharmaceutical Preparation & Substances.
View +8 more Brands for Bharat Serums And Vaccines Limited.
Charges
28 March 2018
Axis Bank Limited
65 Crore
16 August 2017
Export-import Bank Of India
36 Crore
19 June 2017
Axis Bank Limited
65 Crore
21 November 2014
Rbl Bank Limited
35 Crore
31 July 2010
Department Of Biotechnology
1 Crore
16 July 2009
Bank Of Baroda
45 Crore
07 July 2009
Bank Of Baroda
36 Crore
29 June 2009
Department Of Biotechnology
10 Crore
21 September 2007
Idbi Bank Limited
55 Crore
30 June 2007
Dbs Bank Ltd
40 Crore
01 March 2013
Export-import Bank Of India
35 Crore
24 January 2012
Export Import Bank Of India
35 Crore
22 March 2013
Export-import Bank Of India
20 Crore
29 September 2009
Cororation Bank
6 Crore
29 October 2002
Corporation Bank
6 Crore
16 November 2011
Idbi Bank Limited
10 Crore
15 March 2010
Export-import Bank Of India
16 Crore
22 December 2009
Idbi Bank Limited
15 Crore
28 June 2002
Industrial Development Bank Of India Limited
13 Crore
28 June 2002
Idbi Bank Limited
6 Crore
19 February 2008
Icici Bank Limited
20 Crore
25 March 2007
Citi Bank N.a.
13 Crore
15 May 2008
Dbs Bank Limited
8 Crore
07 December 2007
Hdfc Bank Limited
4 Crore
01 July 2002
Hdfc Bank Limited
15 Crore
05 October 2007
Industrial Development Bank Of India Limited
20 Crore
13 November 2003
Co-operative Central Raiffeisen Boerenleenbank B.a.
18 Crore
20 August 2021
Icici Bank Limited
85 Crore
21 November 2014
Others
0
16 July 2009
Bank Of Baroda
0
16 August 2017
Others
0
07 December 2007
Hdfc Bank Limited
0
25 March 2007
Citi Bank N.a.
0
28 June 2002
Industrial Development Bank Of India Limited
0
28 June 2002
Idbi Bank Limited
0
01 July 2002
Hdfc Bank Limited
0
22 March 2013
Export-import Bank Of India
0
01 March 2013
Export-import Bank Of India
0
24 January 2012
Export Import Bank Of India
0
16 November 2011
Idbi Bank Limited
0
31 July 2010
Department Of Biotechnology
0
15 March 2010
Export-import Bank Of India
0
29 October 2002
Corporation Bank
0
13 November 2003
Co-operative Central Raiffeisen Boerenleenbank B.a.
0
22 December 2009
Idbi Bank Limited
0
29 September 2009
Cororation Bank
0
19 February 2008
Icici Bank Limited
0
07 July 2009
Bank Of Baroda
0
29 June 2009
Department Of Biotechnology
0
15 May 2008
Dbs Bank Limited
0
05 October 2007
Industrial Development Bank Of India Limited
0
21 November 2014
Others
0
16 July 2009
Bank Of Baroda
0
16 August 2017
Others
0
07 December 2007
Hdfc Bank Limited
0
25 March 2007
Citi Bank N.a.
0
28 June 2002
Industrial Development Bank Of India Limited
0
28 June 2002
Idbi Bank Limited
0
01 July 2002
Hdfc Bank Limited
0
22 March 2013
Export-import Bank Of India
0
01 March 2013
Export-import Bank Of India
0
24 January 2012
Export Import Bank Of India
0
16 November 2011
Idbi Bank Limited
0
31 July 2010
Department Of Biotechnology
0
15 March 2010
Export-import Bank Of India
0
29 October 2002
Corporation Bank
0
13 November 2003
Co-operative Central Raiffeisen Boerenleenbank B.a.
0
22 December 2009
Idbi Bank Limited
0
29 September 2009
Cororation Bank
0
19 February 2008
Icici Bank Limited
0
07 July 2009
Bank Of Baroda
0
29 June 2009
Department Of Biotechnology
0
15 May 2008
Dbs Bank Limited
0
05 October 2007
Industrial Development Bank Of India Limited
0
Documents
Form INC-28-25102021-signed
Form CHG-1-22102021_signed
Optional Attachment-(1)-22102021
Instrument(s) of creation or modification of charge;-22102021
Particulars of all joint charge holders;-22102021
CERTIFICATE OF REGISTRATION OF CHARGE-20211022
Form AOC-4(XBRL)-03102021-signed
Form MGT-14-29092021-signed
Letter of the charge holder stating that the amount has been satisfied-23092021
Form CHG-4-23092021_signed
CERTIFICATE OF SATISFACTION OF CHARGE-20210923
Copy of court order or NCLT or CLB or order by any other competent authority.-22092021
Optional Attachment-(1)-22092021
Optional Attachment-(1)-20092021
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-20092021
Form CHG-4-15092021
CERTIFICATE OF SATISFACTION OF CHARGE-20210917
Statement of subsidiaries as per section 129-Form AOC-1 (To be attached in respect of Foreign subsidiaries)-16092021
Optional Attachment-(1)-16092021
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-16092021
List of share holders, debenture holders;-16092021
XBRL document in respect Consolidated financial statement-16092021
Copy of MGT-8-16092021
Instrument(s) of creation or modification of charge;-16092021
Letter of the charge holder stating that the amount has been satisfied-15092021
Particulars of all joint charge holders;-16092021
Form CHG-1-16092021_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20210916
Form MGT-7-16092021_signed
Letter of the charge holder stating that the amount has been satisfied-02092021
